PRIMROSE PHARMA
Timeline
6 events since 2016Capital
Filings
Financial
201620182020202220242026
2019
Annual accounts 2018 filed PDFabbreviated format · 20 days before the deadline
2018
Merger: absorbed by Etixx Sports PDFCapital €100,000, annual accounts 2018
Merger proposal: to be absorbed by Etixx SportsPermanent representatives: , and · Capital increase of €100,000 · Board meeting of 24-08-201815 points ▸
- Board meeting, 24-08-2018
- Power of attorney, (director)
- Power of attorney, (director)
- Board composition, (director)
- Board composition, (director)
- Board composition, (director)
- Permanent representative,
- Permanent representative,
- Permanent representative,
- Capital, €100,000, 100 shares
- Capital, €162,000, 2,100 shares
- Board composition, (manager)
- Capital, €100,000, 1,000 shares
- Capital increase, €100,000
- Accounting effect, 01-07-2018
- The deed holds 15 more points.
Liquidity more than 15 times current ratio 69.41 The current ratio rises from 4.50 to 69.41. Short-term debt falls from €163,291 to €11,472.
Annual accounts 2017 filed PDFabbreviated format · 7 days before the deadline
2016
IncorporationFounding capital of €100,000, 1,000 shares · Founders: and · Appointment: (manager)5 points ▸
- Incorporation, 27-05-2016
- Founder,
- Founder,
- Founding capital, €100,000, 1,000 shares
- Director appointment, (manager (not named in the articles))
- The deed holds 2 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
The deed of incorporation of PRIMROSE PHARMA was published in the Belgian Official Gazette on 7 June 2016.1 The company has filed 2 sets of annual accounts, the latest for financial year 2018.2 In 2018 the company was absorbed by merger into Etixx Sports.3